248 related articles for article (PubMed ID: 16412210)
61. The expression of MUM1 in cutaneous T-cell lymphoproliferative disorders.
Wasco MJ; Fullen D; Su L; Ma L
Hum Pathol; 2008 Apr; 39(4):557-63. PubMed ID: 18234282
[TBL] [Abstract][Full Text] [Related]
62. Expression of interleukin-18 and caspase-1 in cutaneous T-cell lymphoma.
Yamanaka K; Clark R; Dowgiert R; Hurwitz D; Shibata M; Rich BE; Hirahara K; Jones DA; Eapen S; Mizutani H; Kupper TS
Clin Cancer Res; 2006 Jan; 12(2):376-82. PubMed ID: 16428475
[TBL] [Abstract][Full Text] [Related]
63. T-cell primary cutaneous lymphomas. A clinicopathological and immunohistochemical study.
Caruntu ID; Mardari V; Radulescu D; Chirana A; Cozma L; Taranu T; Dobrescu G
Pol J Pathol; 2007; 58(4):259-65. PubMed ID: 18459460
[TBL] [Abstract][Full Text] [Related]
64. Clinical experience: practical management of five patients with cutaneous T-cell lymphoma (CTCL)-related symptoms.
Dummer R; Foss F; Dreno B; Bagot M
Semin Oncol; 2006 Feb; 33(1 Suppl 3):S26-32. PubMed ID: 16516673
[TBL] [Abstract][Full Text] [Related]
65. Cutaneous lymphomas.
Smith BD; Wilson LD
Semin Radiat Oncol; 2007 Jul; 17(3):158-68. PubMed ID: 17591562
[TBL] [Abstract][Full Text] [Related]
66. Biological insights into the pathogenesis of cutaneous T-cell lymphomas (CTCL).
Whittaker S
Semin Oncol; 2006 Feb; 33(1 Suppl 3):S3-6. PubMed ID: 16516668
[TBL] [Abstract][Full Text] [Related]
67. A comparison of morphologic features, flow cytometry, TCR-Vbeta analysis, and TCR-PCR in qualitative and quantitative assessment of peripheral blood involvement by Sézary syndrome.
Morice WG; Katzmann JA; Pittelkow MR; el-Azhary RA; Gibson LE; Hanson CA
Am J Clin Pathol; 2006 Mar; 125(3):364-74. PubMed ID: 16613339
[TBL] [Abstract][Full Text] [Related]
68. Differential expression of TOX by skin-infiltrating T cells in Sézary syndrome and erythrodermic dermatitis.
Boonk SE; Çetinözman F; Vermeer MH; Jansen PM; Willemze R
J Cutan Pathol; 2015 Sep; 42(9):604-9. PubMed ID: 25777533
[TBL] [Abstract][Full Text] [Related]
69. Human herpesvirus 7 detection by quantitative real time polymerase chain reaction in primary cutaneous T-cell lymphomas and healthy subjects: lack of a pathogenic role.
Ponti R; Bergallo M; Costa C; Quaglino P; Fierro MT; Comessatti A; Stroppiana E; Sidoti F; Merlino C; Novelli M; Alotto D; Cavallo R; Bernengo MG
Br J Dermatol; 2008 Nov; 159(5):1131-7. PubMed ID: 18782321
[TBL] [Abstract][Full Text] [Related]
70. Quantitative electron microscopy in the early diagnosis of cutaneous T-cell lymphomas. A long-term follow-up study of 77 patients.
Willemze R; Cornelisse CJ; Hermans J; Pardoel VP; Van Vloten WA; Meijer CJ
Am J Pathol; 1986 Apr; 123(1):166-73. PubMed ID: 2421579
[TBL] [Abstract][Full Text] [Related]
71. Evaluation of blood parameters for the monitoring of erythrodermic cutaneous T-cell lymphoma.
Vandersee S; Humme D; Terhorst D; Almohamad A; Möbs M; Beyer M
J Dtsch Dermatol Ges; 2015 Jan; 13(1):30-6. PubMed ID: 25640490
[TBL] [Abstract][Full Text] [Related]
72. Molecular cytogenetics in the study of cutaneous T-cell lymphomas (CTCL).
Karenko L; Hahtola S; Ranki A
Cytogenet Genome Res; 2007; 118(2-4):353-61. PubMed ID: 18000390
[TBL] [Abstract][Full Text] [Related]
73. [Pigmented erythroderma in AIDS. 5 cases].
Picard-Dahan C; Le Guyadec T; Grossin M; Féton N; Raphaël M; Simonpoli AM; Crickx B; Belaïch S
Ann Dermatol Venereol; 1996; 123(5):307-13. PubMed ID: 8761082
[TBL] [Abstract][Full Text] [Related]
74. Diagnostic signs of cutaneous lymphomas.
Burg G; Kempf W; Dummer R
J Eur Acad Dermatol Venereol; 2001 Jul; 15(4):358-60. PubMed ID: 11730054
[No Abstract] [Full Text] [Related]
75. CD13 and TCR clone: markers of early mycosis fungoides.
Bernier C; Nguyen JM; Quéreux G; Renault JJ; Bureau B; Dreno B
Acta Derm Venereol; 2007; 87(2):155-9. PubMed ID: 17340024
[TBL] [Abstract][Full Text] [Related]
76. Histopathologic diagnosis of lymphomatous versus inflammatory erythroderma: a morphologic and phenotypic study on 47 skin biopsies.
Ram-Wolff C; Martin-Garcia N; Bensussan A; Bagot M; Ortonne N
Am J Dermatopathol; 2010 Dec; 32(8):755-63. PubMed ID: 20559121
[TBL] [Abstract][Full Text] [Related]
77. CD7 expression in reactive and malignant human skin T-lymphocytes.
Alaibac M; Pigozzi B; Belloni-Fortina A; Michelotto A; Saponeri A; Peserico A
Anticancer Res; 2003; 23(3B):2707-10. PubMed ID: 12894562
[TBL] [Abstract][Full Text] [Related]
78. The protean spectrum of non-Hodgkin lymphomas with prominent involvement of subcutaneous fat.
Massone C; Lozzi GP; Egberts F; Fink-Puches R; Cota C; Kerl H; Cerroni L
J Cutan Pathol; 2006 Jun; 33(6):418-25. PubMed ID: 16776717
[TBL] [Abstract][Full Text] [Related]
79. Expression of programmed death-1 in skin biopsies of benign inflammatory vs. lymphomatous erythroderma.
Çetinözman F; Jansen PM; Willemze R
Br J Dermatol; 2014 Sep; 171(3):499-504. PubMed ID: 24601935
[TBL] [Abstract][Full Text] [Related]
80. CD20 positive mycosis fungoides: a case report.
Sen F; Kang S; Cangiarella J; Kamino H; Hymes K
J Cutan Pathol; 2008 Apr; 35(4):398-403. PubMed ID: 18261116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
